Journal article
Predicting out-of-office blood pressure (Proof-BP) in the clinic for the diagnosis of hypertension in primary care: An economic evaluation
- Abstract:
- Clinical guidelines in the US and UK recommend that individuals with suspected hypertension should have ambulatory blood pressure (BP) monitoring (ABPM) to confirm the diagnosis. This approach reduces misdiagnosis due to white coat hypertension but will not identify people with masked hypertension who may benefit from treatment. The Predicting Out-of-Office Blood Pressure (PROOF-BP) algorithm predicts masked and white coat hypertension based on patient characteristics and clinic BP, improving the accuracy of diagnosis whilst limiting subsequent ABPM. This study assessed the cost-effectiveness of using this tool in diagnosing hypertension in Primary Care. A Markov cost-utility cohort model was developed to compare diagnostic strategies: the PROOF-BP approach, including those with clinic BP ≥130/80mmHg who receive ABPM as guided by the algorithm, compared to current standard diagnostic strategies including those with clinic BP ≥140/90mmHg combined with further monitoring (ABPM as reference, clinic and home monitoring also assessed). The model adopted a lifetime horizon with a three month time-cycle, taking a UK Health Service/Personal Social Services perspective. The PROOF-BP algorithm was cost-effective in screening all patients with clinic BP ≥130/80mmHg compared to current strategies which only screen those with clinic BP ≥140/90mmHg, provided healthcare providers were willing to pay up to £20,000 ($26,000)/quality-adjusted life year gained. Deterministic and probabilistic sensitivity analyses supported the base-case findings. The PROOF-BP algorithm appears to be cost-effective compared to the conventional BP diagnostic options in Primary Care. Its use in clinical practice is likely to lead to reduced cardiovascular disease, death and disability.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 547.5KB, Terms of use)
-
- Publisher copy:
- 10.1161/HYPERTENSIONAHA.117.10244
Authors
- Publisher:
- American Heart Association
- Journal:
- Hypertension More from this journal
- Volume:
- 71
- Issue:
- 2
- Pages:
- 250-261
- Publication date:
- 2017-12-04
- Acceptance date:
- 2017-11-01
- DOI:
- EISSN:
-
1524-4563
- ISSN:
-
0194-911X
- Keywords:
- Pubs id:
-
pubs:743797
- UUID:
-
uuid:e6a0340c-6efd-46c5-8188-76ab63d3b8e7
- Local pid:
-
pubs:743797
- Source identifiers:
-
743797
- Deposit date:
-
2017-11-08
- ARK identifier:
Terms of use
- Copyright holder:
- *Copyright holder name ("et al" as required)*
- Copyright date:
- 2017
- Notes:
- © 2017 American Heart Association, Inc. This is the accepted manuscript version of the article. The final version is available online from American Heart Association at: http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.10244
If you are the owner of this record, you can report an update to it here: Report update to this record